ALLMedicine™ Non-small Cell Lung Cancer Staging Center
Research & Reviews 29 results
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.
Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...
https://doi.org/10.1093/ajcp/aqz146
American Journal of Clinical Pathology; Caupena C, Esteban L et. al.
Oct 16th, 2019 - In patients with lung cancer undergoing mediastinal staging through endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), decisions are based on rapid on-site evaluation (ROSE) findings. We aimed to analyze the concordance ...
https://doi.org/10.1016/j.jtho.2019.03.015
Journal of Thoracic Oncology : Official Publication of Th... Kratz JR, Haro GJ et. al.
Apr 8th, 2019 - Despite adoption of molecular biomarkers in the management of NSCLC, the recently adopted eighth edition of the TNM staging system utilized only clinicopathologic characteristics and validated improvement in risk stratification of early-stage dise...
https://doi.org/10.1080/13645706.2018.1513944
Minimally Invasive Therapy & Allied Technologies : MITAT ... Ozturk A, Gullu YT
Sep 28th, 2018 - Objective: To determine the correlation and/or discrepancies between positron emission tomography (PET-CT) findings, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and surgery in the staging of non-small cell lung car...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286257
European Journal of Nuclear Medicine and Molecular Imaging; Pu Y, Zhang JX et. al.
Jun 8th, 2018 - We hypothesized that whole-body metabolic tumor volume (MTVwb) could be used to supplement non-small cell lung cancer (NSCLC) staging due to its independent prognostic value. The goal of this study was to develop and validate a novel MTVwb risk st...
Guidelines 4 results
http://ascopubs.org/full/doi/10.1200/JCO.2017.74.6065
Nasser Hanna
Oct 19th, 2017 - Provide evidence-based recommendations updating the 2015 ASCO guideline on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC).
https://academic.oup.com/annonc/article/28/suppl_4/iv1/3958156
Postmus, P. E.
Jul 12th, 2017 - Lung cancer is the leading cause of cancer mortality worldwide with 1. 8 million newly diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1].
https://www.thegreenjournal.com/article/S0167-8140(17)30376-6/fulltext
Guckenberger, M.,et al
Jun 30th, 2017 - Stereotactic body radiotherapy (SBRT) has become the standard of care for medically inoperable patients with peripherally located, early stage non-small cell lung cancer (NSCLC), and for those refusing surgical resection. Despite the availability.
https://www.practicalradonc.org/article/S1879-8500(15)00082-X/abstract
George Rodrigues
Jun 29th, 2015 - This guideline addresses five key questions related to appropriate use of RT in the definitive and adjuvant settings for locally advanced NSCLC. First, it looks at ideal radical RT dose fractionation for radiotherapy alone and for chemoradiation.
Clinicaltrials.gov 37 results
https://doi.org/10.1016/j.acra.2020.04.007
Academic Radiology; Wu DY, de Hoyos A et. al.
Jun 21st, 2020 - Examine the accuracy of clinical non-small cell lung cancer staging and tumor length measurements, which are critical to prognosis and treatment planning. Compare clinical and pathological staging and lengths using 10,320 2016 National Cancer Inst...
https://doi.org/10.1093/ajcp/aqz146
American Journal of Clinical Pathology; Caupena C, Esteban L et. al.
Oct 16th, 2019 - In patients with lung cancer undergoing mediastinal staging through endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), decisions are based on rapid on-site evaluation (ROSE) findings. We aimed to analyze the concordance ...
https://doi.org/10.1016/j.jtho.2019.03.015
Journal of Thoracic Oncology : Official Publication of Th... Kratz JR, Haro GJ et. al.
Apr 8th, 2019 - Despite adoption of molecular biomarkers in the management of NSCLC, the recently adopted eighth edition of the TNM staging system utilized only clinicopathologic characteristics and validated improvement in risk stratification of early-stage dise...
https://doi.org/10.1080/13645706.2018.1513944
Minimally Invasive Therapy & Allied Technologies : MITAT ... Ozturk A, Gullu YT
Sep 28th, 2018 - Objective: To determine the correlation and/or discrepancies between positron emission tomography (PET-CT) findings, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and surgery in the staging of non-small cell lung car...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286257
European Journal of Nuclear Medicine and Molecular Imaging; Pu Y, Zhang JX et. al.
Jun 8th, 2018 - We hypothesized that whole-body metabolic tumor volume (MTVwb) could be used to supplement non-small cell lung cancer (NSCLC) staging due to its independent prognostic value. The goal of this study was to develop and validate a novel MTVwb risk st...
